{
    "startDate": "2017-07-01",
    "endDate": "2017-09-30",
    "year": "2018",
    "quarter": "Q1",
    "symbol": "INBP",
    "data": {
        "bs": [
            {
                "label": "Cash",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 284000
            },
            {
                "label": "Accounts receivable, net",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 2673000
            },
            {
                "label": "Inventories",
                "concept": "InventoryNet",
                "unit": "usd",
                "value": 7042000
            },
            {
                "label": "Other current assets",
                "concept": "OtherAssetsCurrent",
                "unit": "usd",
                "value": 636000
            },
            {
                "label": "us-gaap_AssetsCurrent",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 10635000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 1632000
            },
            {
                "label": "Deferred tax assets, net",
                "concept": "DeferredTaxAssetsLiabilitiesNetNoncurrent",
                "unit": "usd",
                "value": 877000
            },
            {
                "label": "Security deposits and other assets",
                "concept": "DepositsAssetsNoncurrent",
                "unit": "usd",
                "value": 237000
            },
            {
                "label": "us-gaap_AssetsCurrent",
                "concept": "Assets",
                "unit": "usd",
                "value": 13381000
            },
            {
                "label": "Advances under revolving credit facility",
                "concept": "LinesOfCreditCurrent",
                "unit": "usd",
                "value": 3904000
            },
            {
                "label": "Accounts payable (includes $77 due to related party)",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 3722000
            },
            {
                "label": "Accrued expenses and other current liabilities",
                "concept": "AccruedLiabilitiesAndOtherLiabilities",
                "unit": "usd",
                "value": 1208000
            },
            {
                "label": "Current portion of long term debt, net",
                "concept": "LongTermDebtCurrent",
                "unit": "usd",
                "value": 1031000
            },
            {
                "label": "us-gaap_LiabilitiesCurrent",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 9865000
            },
            {
                "label": "Convertible Note payable, net - CD Financial, LLC",
                "concept": "NotesPayableRelatedPartiesNoncurrent",
                "unit": "usd",
                "value": 5233000
            },
            {
                "label": "Long term debt, net",
                "concept": "LongTermDebtNoncurrent",
                "unit": "usd",
                "value": 3766000
            },
            {
                "label": "Derivative liability",
                "concept": "DerivativeLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 621000
            },
            {
                "label": "us-gaap_LiabilitiesAndStockholdersEquity",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 19485000
            },
            {
                "label": "Commitments and Contingencies Disclosure [Text Block]",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common Stock, $0.002 par value; 50,000,000 shares authorized; 21,170,074 and 21,135,174 shares issued and outstanding, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 42000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 44763000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -50810000
            },
            {
                "label": "us-gaap_TreasuryStockValue",
                "concept": "TreasuryStockValue",
                "unit": "usd",
                "value": 99000
            },
            {
                "label": "Stockholders' Deficiency:",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": -6104000
            },
            {
                "label": "us-gaap_LiabilitiesAndStockholdersEquity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 13381000
            }
        ],
        "cf": [
            {
                "label": "Net (loss) income",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -179000
            },
            {
                "label": "us-gaap_DepreciationDepletionAndAmortization",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 100000
            },
            {
                "label": "Accretion of financing instruments and other non cash interest",
                "concept": "AccretionExpense",
                "unit": "usd",
                "value": 26000
            },
            {
                "label": "Stock based compensation",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 4000
            },
            {
                "label": "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount",
                "concept": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
                "unit": "usd",
                "value": 54000
            },
            {
                "label": "Impairment charge on investment in iBio, Inc.",
                "concept": "CostmethodInvestmentsOtherThanTemporaryImpairment",
                "unit": "usd",
                "value": 83000
            },
            {
                "label": "Change in fair value of derivative liabilities",
                "concept": "IncreaseDecreaseInDerivativeLiabilities",
                "unit": "usd",
                "value": 118000
            },
            {
                "label": "us-gaap_IncreaseDecreaseInAccountsReceivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": -1347000
            },
            {
                "label": "us-gaap_IncreaseDecreaseInInventories",
                "concept": "IncreaseDecreaseInInventories",
                "unit": "usd",
                "value": -603000
            },
            {
                "label": "us-gaap_IncreaseDecreaseInOtherCurrentAssets",
                "concept": "IncreaseDecreaseInOtherCurrentAssets",
                "unit": "usd",
                "value": -35000
            },
            {
                "label": "us-gaap_IncreaseDecreaseInSecurityDeposits",
                "concept": "IncreaseDecreaseInSecurityDeposits",
                "unit": "usd",
                "value": -48000
            },
            {
                "label": "us-gaap_IncreaseDecreaseInAccountsPayable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": -455000
            },
            {
                "label": "Accrued expenses and other liabilities",
                "concept": "IncreaseDecreaseInOtherAccruedLiabilities",
                "unit": "usd",
                "value": 24000
            },
            {
                "label": "Cash flows provided by operating activities:",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": 1604000
            },
            {
                "label": "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 107000
            },
            {
                "label": "Cash flows from investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -107000
            },
            {
                "label": "us-gaap_ProceedsFromLinesOfCredit",
                "concept": "ProceedsFromLinesOfCredit",
                "unit": "usd",
                "value": 9997000
            },
            {
                "label": "us-gaap_RepaymentsOfLinesOfCredit",
                "concept": "RepaymentsOfLinesOfCredit",
                "unit": "usd",
                "value": 10768000
            },
            {
                "label": "us-gaap_RepaymentsOfNotesPayable",
                "concept": "RepaymentsOfNotesPayable",
                "unit": "usd",
                "value": 544000
            },
            {
                "label": "us-gaap_RepaymentsOfLongTermCapitalLeaseObligations",
                "concept": "RepaymentsOfLongTermCapitalLeaseObligations",
                "unit": "usd",
                "value": 30000
            },
            {
                "label": "Cash flows from financing activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": -1345000
            },
            {
                "label": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease",
                "unit": "usd",
                "value": 152000
            },
            {
                "label": "Interest paid",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": 198000
            },
            {
                "label": "Income taxes paid",
                "concept": "IncomeTaxesPaid",
                "unit": "usd",
                "value": "N/A"
            }
        ],
        "ic": [
            {
                "label": "us-gaap_SalesRevenueGoodsNet",
                "concept": "SalesRevenueGoodsNet",
                "unit": "usd",
                "value": 9770000
            },
            {
                "label": "Cost of sales",
                "concept": "CostOfGoodsSold",
                "unit": "usd",
                "value": 8765000
            },
            {
                "label": "Gross Profit",
                "concept": "GrossProfit",
                "unit": "usd",
                "value": 1005000
            },
            {
                "label": "Selling and administrative expenses",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 794000
            },
            {
                "label": "us-gaap_OperatingIncomeLoss",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": 211000
            },
            {
                "label": "us-gaap_InterestExpense",
                "concept": "InterestExpense",
                "unit": "usd",
                "value": 233000
            },
            {
                "label": "us-gaap_DerivativeGainLossOnDerivativeNet",
                "concept": "DerivativeGainLossOnDerivativeNet",
                "unit": "usd",
                "value": -118000
            },
            {
                "label": "Impairment charge on investment in iBio, Inc.",
                "concept": "CostmethodInvestmentsOtherThanTemporaryImpairment",
                "unit": "usd",
                "value": 83000
            },
            {
                "label": "Other income, net",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "us-gaap_NonoperatingIncomeExpense",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": -434000
            },
            {
                "label": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -223000
            },
            {
                "label": "Income tax (benefit) expense, net",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": -44000
            },
            {
                "label": "Net (loss) income",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -179000
            },
            {
                "label": "Basic net (loss) income per common share (in dollars per share)",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": -0.01
            },
            {
                "label": "Diluted net (loss) income per common share (in dollars per share)",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": -0.01
            },
            {
                "label": "Weighted average common shares outstanding - basic (in shares)",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 21135174
            },
            {
                "label": "Add: Equivalent shares outstanding (in shares)",
                "concept": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
                "unit": "shares",
                "value": "N/A"
            },
            {
                "label": "Shares issuable upon conversion of Convertible Debt - CD Financial, LLC (in shares)",
                "concept": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities",
                "unit": "shares",
                "value": "N/A"
            },
            {
                "label": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 21135174
            }
        ]
    }
}